日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/09/18 | 1,610 | 1,610 | 1,609 | 1,609 | -1 | -0.1% | 2,100 |
| 2025/09/17 | 1,604 | 1,610 | 1,600 | 1,610 | +6 | +0.4% | 1,800 |
| 2025/09/16 | 1,597 | 1,604 | 1,575 | 1,604 | +29 | +1.8% | 3,300 |
| 2025/09/12 | 1,571 | 1,586 | 1,559 | 1,575 | +44 | +2.9% | 3,100 |
| 2025/09/11 | 1,600 | 1,601 | 1,502 | 1,531 | -81 | -5% | 12,600 |
| 2025/09/10 | 1,620 | 1,621 | 1,600 | 1,612 | -7 | -0.4% | 2,100 |
| 2025/09/09 | 1,628 | 1,628 | 1,607 | 1,619 | -10 | -0.6% | 700 |
| 2025/09/08 | 1,615 | 1,634 | 1,606 | 1,629 | +14 | +0.9% | 4,000 |
| 2025/09/05 | 1,606 | 1,615 | 1,606 | 1,615 | +4 | +0.2% | 400 |
| 2025/09/04 | 1,611 | 1,611 | 1,611 | 1,611 | -19 | -1.2% | 200 |
| 2025/09/03 | 1,624 | 1,630 | 1,619 | 1,630 | +6 | +0.4% | 400 |
| 2025/09/02 | 1,633 | 1,633 | 1,624 | 1,624 | -9 | -0.6% | 300 |
| 2025/09/01 | 1,623 | 1,633 | 1,613 | 1,633 | +22 | +1.4% | 2,100 |
| 2025/08/29 | 1,616 | 1,620 | 1,611 | 1,611 | -6 | -0.4% | 1,300 |
| 2025/08/28 | 1,635 | 1,636 | 1,580 | 1,617 | -2 | -0.1% | 3,800 |
| 2025/08/27 | 1,620 | 1,630 | 1,610 | 1,619 | +9 | +0.6% | 2,500 |
| 2025/08/26 | 1,602 | 1,625 | 1,600 | 1,610 | -15 | -0.9% | 3,000 |
| 2025/08/25 | 1,615 | 1,630 | 1,561 | 1,625 | +14 | +0.9% | 5,600 |
| 2025/08/22 | 1,618 | 1,618 | 1,611 | 1,611 | -7 | -0.4% | 1,700 |
| 2025/08/21 | 1,603 | 1,618 | 1,603 | 1,618 | +18 | +1.1% | 2,400 |
| 2025/08/20 | 1,591 | 1,605 | 1,591 | 1,600 | +11 | +0.7% | 1,800 |
| 2025/08/19 | 1,560 | 1,590 | 1,560 | 1,589 | ±0 | ±0% | 1,300 |
| 2025/08/18 | 1,600 | 1,605 | 1,568 | 1,589 | -11 | -0.7% | 2,300 |
| 2025/08/15 | 1,583 | 1,600 | 1,583 | 1,600 | +17 | +1.1% | 900 |
| 2025/08/14 | 1,606 | 1,607 | 1,545 | 1,583 | -7 | -0.4% | 5,500 |
| 2025/08/13 | 1,570 | 1,601 | 1,555 | 1,590 | +18 | +1.1% | 5,800 |
| 2025/08/12 | 1,583 | 1,590 | 1,571 | 1,572 | -11 | -0.7% | 1,900 |
| 2025/08/08 | 1,573 | 1,583 | 1,525 | 1,583 | +10 | +0.6% | 3,900 |
| 2025/08/07 | 1,574 | 1,574 | 1,542 | 1,573 | -1 | -0.1% | 4,100 |
| 2025/08/06 | 1,537 | 1,577 | 1,537 | 1,574 | +37 | +2.4% | 4,100 |
| 2025/08/05 | 1,533 | 1,560 | 1,530 | 1,537 | -4 | -0.3% | 1,400 |
| 2025/08/04 | 1,538 | 1,568 | 1,522 | 1,541 | +3 | +0.2% | 3,200 |
| 2025/08/01 | 1,550 | 1,594 | 1,514 | 1,538 | -1 | -0.1% | 6,200 |
| 2025/07/31 | 1,512 | 1,539 | 1,512 | 1,539 | +34 | +2.3% | 2,200 |
| 2025/07/30 | 1,510 | 1,512 | 1,500 | 1,505 | -5 | -0.3% | 800 |
| 2025/07/29 | 1,500 | 1,510 | 1,500 | 1,510 | +5 | +0.3% | 1,100 |
| 2025/07/28 | 1,496 | 1,505 | 1,496 | 1,505 | +2 | +0.1% | 2,400 |
| 2025/07/25 | 1,493 | 1,503 | 1,493 | 1,503 | +10 | +0.7% | 1,400 |
| 2025/07/24 | 1,488 | 1,500 | 1,488 | 1,493 | +2 | +0.1% | 3,600 |
| 2025/07/23 | 1,488 | 1,501 | 1,482 | 1,491 | -10 | -0.7% | 6,700 |
| 2025/07/22 | 1,500 | 1,501 | 1,489 | 1,501 | ±0 | ±0% | 2,200 |
| 2025/07/18 | 1,500 | 1,501 | 1,485 | 1,501 | +1 | +0.1% | 3,200 |
| 2025/07/17 | 1,480 | 1,500 | 1,480 | 1,500 | +3 | +0.2% | 1,500 |
| 2025/07/16 | 1,487 | 1,497 | 1,482 | 1,497 | +10 | +0.7% | 1,000 |
| 2025/07/15 | 1,492 | 1,500 | 1,475 | 1,487 | -13 | -0.9% | 2,100 |
| 2025/07/14 | 1,500 | 1,500 | 1,491 | 1,500 | ±0 | ±0% | 600 |
| 2025/07/11 | 1,500 | 1,510 | 1,491 | 1,500 | -3 | -0.2% | 7,400 |
| 2025/07/10 | 1,493 | 1,503 | 1,491 | 1,503 | +8 | +0.5% | 400 |
| 2025/07/09 | 1,504 | 1,504 | 1,486 | 1,495 | -9 | -0.6% | 1,500 |
| 2025/07/08 | 1,506 | 1,508 | 1,496 | 1,504 | +8 | +0.5% | 4,500 |
1～
50
件表示中 / 3786件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 160,900円 | +7.5% | -77.4% | 3.11% | 38.70倍 | 0.30倍 |
|
後発薬中堅、検査薬事業が第２の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
| ティムス | 15,700円 | - | - | 0.00% | - | 2.56倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国ＣＯＲＸＥＬ社に導出 |
| シンバイオ | 14,100円 | -42.9% | - | 0.00% | - | 3.40倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬ＢＣＶの開発に注力 |
| ＰＲＩＳＭＢｉｏ | 17,100円 | +14.8% | - | 0.00% | - | 2.06倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
| モダリス | 8,000円 | - | - | 0.00% | - | 1.95倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
市場注目の銘柄
チャート関連のコラム
